International Editorial Advisory Board

This international board of reputable scientists acts independently and represents the interests of the different parties/stakeholders involved.

Members of International Editorial Advisory Board:

Arpah Abas, BPharm, Former Head of Biotech Section, Ministry of Health, Malaysia
Professor Saleh Alsuwayeh, PhD, Professor of Pharmaceutics, Chairman, Technical Registration Committee, Saudi Food & Drug Authority, Saudi Arabia
Professor Alain Astier, PharmD, PhD, Professor of Clinical Pharmacy and Biotechnics, Head of Pharmacy Department, Henri Mondor University Hospital, France
Dr Edwin Jose Asturias, MD, Assistant Professor of Pediatrics-General Pediatrics, University of Colorado-Denver, USA
Dr Christoph Baumgärtel, MD, MSc, Head of Department for Medical Assessment, AGES PharmMed, Austria
Professor Daniel Kelly Benjamin Jr, MD, MPH, PhD, Professor with Tenure, Pediatric Infectious Diseases, Duke University, USA
Professor Henning Blume, Founder, SocraTec R & D GmbH, Germany
Ms Boontarika Boonyapiwat, Pharmacist, Bureau of Drug and Narcotic, Department of Medical Sciences, Ministry of Public Health, Thailand
Dr Vera Brinks, MSc, PhD, Postdoctoral Researcher, Utrecht University, The Netherlands
Dr Frank Xiao Chen, PhD, The First Affiliated Hospital, Sun Yat-sun University, China
Professor Abdol Majid Cheraghali, PharmD, PhD, Professor of Pharmacology and Toxicology, Department of Pharmacology, BMS University, Advisor to Managing Director, Iran Blood Transfusion Organisation, Iran
Professor Moses SS Chow, PharmD, Professor of Pharmacy Practice and Director, Center for Advancement of Drug Research and Evaluation, College of Pharmacy, Western University of Health Sciences, Pomona, USA
Professor Shein-Chung Chow, PhD, Professor of Biostatistics and Bioinformatics, Duke University School of Medicine, USA
Associate Professor Joshua P Cohen, PhD, Research Associate Professor – generics, Tufts University, USA
Professor Theodor Dingermann, PhD, Director, Institut für Pharmazeutische Biologie, Geöthe University, Germany
Professor Yousry El-Sayed, PhD, Professor of Pharmaceutics, Alexandra University, Egypt
Professor Laszlo Endrenyi, DSc, PhD, Emeritus Professor of Pharmacology and Biostatistics, University of Toronto, Canada
Professor Richard Gabriel Frank, PhD, Professor of Health Economics, Harvard University Medical School, USA
Professor Wolfgang Frieß, PhD, Professor of Pharmaceutics, University München, Germany
Professor Joseph Gal, PhD, Professor of Medicine and Pathology, University of Colorado School of Medicine, USA
Professor Livio Garattini, Head of CESAV, Mario Negri Institute, Italy
Dr Brian Godman, PhD, University of Liverpool Management School, UK
Andy Gray, MScPharm, FPS, FFIP, Pharmacist, Senior Lecturer, University of KwaZulu-Natal, South Africa
Professor Lars L Gustafsson, PhD, Professor of Clinical Pharmacology, Karolinska Institutet, Sweden
Dr Kalle Hoppu, MD, PhD, Director, Poison Information Center, Finland
Ms Wichuda Jariyapan, Medical Scientist/Expert, Institute of Biological Products, Department of Medical Sciences, Ministry of Public Health, Thailand
Dr Toru Kawanishi, PhD, Head of Division of Drugs – small molecules, National Institute of Health Sciences, Japan
Dr Nana Kawasaki, PhD, Professor, Graduate School of Medical Life Science, Yokohama City University, Japan
Professor Gregory Kearns, PharmD, PhD, Professor of Paediatrics and Pharmacology, University of Missouri-Kansas City; President, Arkansas Children’s Hospital Research Institute, Senior Vice President, Arkansas Children’s Hospital, USA
Dr Agnes V Klein, MD, DPH, Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics, Biologics and Genetic Therapies Directorate, Canada
Dr Ivana Knezevic, MD, PhD, Scientist, Technologies, Standards and Norms Team, Group Lead, Norms and Standards for Biologicals, Department of Essential Medicines and Health Products (EMP), Health Systems and Innovation (HIS) Cluster, World Health Organization, Switzerland
Professor Marc Koopmanschap, PhD, Associate Professor of Health Economics, Institute of Health Policy and Management and Institute for Medical Technology Assessment, Erasmus University Rotterdam, The Netherlands
Professor Pekka Kurki, LKT/MD, PhD, Research Professor, Finnish Medicines Agency Fimea, Finland; Docent/Assistant Professor of Clinical Immunology and Autoimmune Diseases, University of Helsinki, Finland
Professor Richard Laing, MD, Professor of International Public Health, Department of Essential Medicines and Pharmaceutical Policies, World Health Organization, Switzerland (until 27 December 2013); Department of International Health, Boston University, USA (from 15 March 2014)
Dr Gerard Lee, PhD, Secretary and Scientific Director of the British Pharmacopoeia Commission; Former Group Manager, Laboratories and Pharmacopoeia; Medicines and Healthcare Products Regulatory Agency (MHRA)
Dr Frits Lekkerkerker, MD, Chairman, NDA Regulatory Sciences Ltd, The Netherlands
Associate Professor Erika Lietzan, JD, Associate Professor of Law, University of Missouri School of Law, USA
Professor Alan Lyles, ScD, Henry A Rosenberg Professor of Public, Private and Nonprofit Partnerships, School of Public Affairs, USA
Professor Stuart M MacLeod, MD, PhD, BSc (Meds), FRCPC, Professor of Pediatrics and Associate Dean (Research), University of British Columbia, Canada
Professor Håkan Mellstedt, MD, PhD, Professor of Oncologic Biotherapy, Karolinska Institute and Cancer Centre Karolinska, Karolinska University Hospital, Sweden
Dr Janice Reichert, PhD, Former Senior Research Fellow – biologicals at Tufts University, USA
Professor José Ignacio Santos Preciado, MD, Professor and Head of Infectious Diseases, University Of Mexico, Mexico
Professor Graham Sewell, PhD, Professor of Clinical Pharmacy, Head of School of Professions and Associate Dean, University of Plymouth, UK
Professor Marvin Shepherd, PhD, Centennial Professor, Division Head, The University of Texas at Austin, USA
Dr Yeowon Sohn, PhD, Director General, Biopharmaceuticals and Herbal Medicine Evaluation Department,  Ministry of Food and Drug Safety, Korea
Professor Fritz Sörgel, PhD, Director, Institute for Biomedical and Pharmaceutical Research, Germany
Professor László Tóthfalusi, MSc, PhD, Professor of Pharmacometrics, Department of Pharmacodynamics, Semmelweis University, Hungary
Dr Jean Vigneron, PharmD, Department of Pharmacy, CHU de Nancy-Hôpital de Brabois Adultes, France
Dr Sabine Vogler, PhD, Head of Pharma Team, GÖG/ÖBIG, Austria
Dr Janet S Wyatt, PhD, Founding Executive Director and Consultant, Institute of Pediatric Nursing, USA

Number of International Advisory Board (IEAB) Members: 50
Number of resident countries of IEAB Members:  22

Honorary Advisors:

Dr Andreas Seiter, MD, Senior Health Specialist – Pharmaceuticals, The World Bank, USA/Germany
Professor Arnold Vulto, PharmD, PhD, Professor of Hospital Pharmacy, Erasmus University Medical Center, The Netherlands

The Editorial Board and International Editorial Advisory Board are expanding, contact the editorial office for an updated list.

Profile of other International Editorial Board Members will be updated shortly.

Last update: 2017-01-04 Go Back Print

Comments are closed.